GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (ASX:CAN) » Definitions » NonCurrent Deferred Liabilities

Cann Group (ASX:CAN) NonCurrent Deferred Liabilities : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Cann Group NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Cann Group's non-current deferred liabilities for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Cann Group NonCurrent Deferred Liabilities Historical Data

The historical data trend for Cann Group's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group NonCurrent Deferred Liabilities Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cann Group NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Cann Group's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cann Group Business Description

Industry
Traded in Other Exchanges
Address
262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.